Literature DB >> 15682313

Prolonged hepatitis caused by cytomegalovirus and non-alcoholic steatohepatitis in 16-year-old obese boy.

Tatsuo Kanda1, Osamu Yokosuka, Yutaka Suzuki.   

Abstract

UNLABELLED: Recently, the prevalence of non-alcoholic steatohepatitis (NASH) has been increasingly reported in patients with type 2 diabetes and obesity. NASH exists not only in adults but also in children. We report on an 16-year-old boy with prolonged hepatitis associated with NASH after cytomegalovirus hepatitis. Increased transaminase levels recovered in parallel to his weight reduction.
CONCLUSION: Clinicians should be aware of the possibility that prolonged acute hepatitis might be associated with non-alcoholic steatohepatitis in adolescents.

Entities:  

Mesh:

Year:  2005        PMID: 15682313     DOI: 10.1007/s00431-004-1584-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

Review 1.  NASH: from liver diseases to metabolic disorders and back to clinical hepatology.

Authors:  Giulio Marchesini; Gabriele Forlani
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON.

Authors:  H STERN; S D ELEK
Journal:  J Hyg (Lond)       Date:  1965-03

3.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 4.  Nonalcoholic steatohepatitis.

Authors:  A E Reid
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

5.  Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.

Authors:  Giovanni Musso; Roberto Gambino; Franco De Michieli; Maurizio Cassader; Mario Rizzetto; Marilena Durazzo; Emanuela Fagà; Barbara Silli; Gianfranco Pagano
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Quantitative evaluation of cytomegalovirus DNA in infantile hepatitis.

Authors:  T Funato; N Satou; D Abukawa; J Satou; Y Abe; K K Ishii; K Iinuma; M Kaku; T Sasaski
Journal:  J Viral Hepat       Date:  2001-05       Impact factor: 3.728

7.  Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis.

Authors:  Mehmet Koruk; M Cemil Savaş; Omer Yilmaz; Seyithan Tayşi; Metin Karakok; Cemal Gündoğdu; Arif Yilmaz
Journal:  J Clin Gastroenterol       Date:  2003-08       Impact factor: 3.062

8.  Steatohepatitis in obese children: a cause of chronic liver dysfunction.

Authors:  J R Moran; F K Ghishan; S A Halter; H L Greene
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

9.  Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.

Authors:  Y Zen; K Katayanagi; K Tsuneyama; K Harada; I Araki; Y Nakanuma
Journal:  Pathol Int       Date:  2001-02       Impact factor: 2.534

Review 10.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

View more
  3 in total

Review 1.  Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Tatsuo Kanda; Taichiro Goto; Yosuke Hirotsu; Ryota Masuzaki; Mitsuhiko Moriyama; Masao Omata
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

Review 2.  Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Kazushige Nirei; Mitsuhiko Moriyama
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

3.  No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.

Authors:  Masato Nakamura; Tatsuo Kanda; Shingo Nakamoto; Tatsuo Miyamura; Xia Jiang; Shuang Wu; Osamu Yokosuka
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.